✦ LIBER ✦

A Model to Evaluate the Immunogenicity Costs of Tumour Necrosis Factor-Alpha Inhibitors in Patients with Rheumatoid Arthritis

✍ Scribed by Heeg, B.; Majer, I.; Stephens, J.M.; Tarallo, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity of anti-tumour necrosis f

✍ Jung, Seung Min; Kim, Hyun-Sook; Kim, Hae-Rim; Kim, Na Young; Lee, Jung-Hwa; Kim 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Circulating tumour necrosis factor alpha

✍ Klimiuk, P A 📂 Article 📅 2003 🏛 BMJ Publishing Group 🌐 English ⚖ 245 KB

Do rheumatoid arthritis patients have eq

✍ Joëlle M. Hoebert; Aukje K. Mantel-Teeuwisse; Liset van Dijk; Johannes W.J. Bijl 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 339 KB

Repeated therapy with monoclonal antibod

✍ M.J. Elliott; R.N. Maini; M. Feldmann; A. Long-Fox; P. Charles; J.A. Bijl; J.N. 📂 Article 📅 1994 🏛 The Lancet 🌐 English ⚖ 438 KB

PMS28 COST-UTILITY ANALYSIS OF TUMOR NEC

✍ CM Nguyen; M Mendes; M Bounthavong; M Christopher; AP Morreale 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

Tumour necrosis factor alpha gene polymo

✍ Brinkman, B. M.; Huizinga, T. W.; Kurban, S. S.; van der Velde, E. A.; Schreuder 📂 Article 📅 1997 🏛 Oxford University Press 🌐 English ⚖ 104 KB